Bioptic is an AI-first discovery platform built for biopharma research teams to speed up early drug discovery. It combines autonomous AI agents with domain-specific models to search huge chemical libraries, propose high-quality hit candidates, and provide deep insights from scientific publications, patents, and clinical data.
Traditional hit identification and early drug discovery can take months and cost millions. Bioptic uses specialized AI to explore chemical space at massive scale (screening up to tens of billions of compounds), extract valuable scientific intelligence, and deliver purchasable hit lists in about a week — reducing time, cost, and uncertainty.
